Whole cells of Corynebacterium glutamicum were loaded with high cytoplasmic L-isoleucine concentrations, and isoleucine excretion from these cells was studied in terms of mechanism and regulation. The transmembrane isoleucine flux could be differentiated into carrier-mediated uptake, carrier-mediated excretion, and diffusion. After discrimination from the other transmembrane solute movements, the outward-directed flux, which was due to the activity of the isoleucine excretion carrier, was characterized with respect to its energy dependence and its regulation at the level of expression. Isoleucine excretion was shown to function as a secondary transport process, driven by the membrane potential and coupled to the movement of protons, presumably with a stoichiometry of 2:1 (H ؉ /isoleucine). Of a variety of putative transport substrates, only leucine was able to compete for isoleucine at the cis (cytosolic) side of the export carrier. Cytoplasmic isoleucine concentrations higher than 20 mM induce the activity of the isoleucine excretion system. This effect is specific for isoleucine and is inhibited by the presence of chloramphenicol. Apart from leucine, other amino acids and related amino acid analogs are not able to induce isoleucine excretion. The complex pattern of regulation of the isoleucine excretion system at the level of activity and expression is shown to be related to the pattern of regulation of the isoleucine uptake system in C. glutamicum in terms of physiological significance.
Since the discovery that Corynebacterium glutamicum is an effective producer of glutamate (16) , the production of amino acids by coryneform bacteria as well as Escherichia coli has become an important biotechnological process. Starting from C. glutamicum, strains which are able to produce lysine, isoleucine, and other amino acids in remarkable amounts were derived by classical mutagenesis and selection. Since the introduction of recombinant DNA technology, increasing effort has been spent to construct particularly designed strains for purposes of high-yield amino acid production. In the case of isoleucine, the main metabolic regulation point is the threonine dehydratase, which is feedback inhibited by isoleucine. Consequently, deregulation of this enzyme increases the isoleucine yield (9, 20) . Synthesis of L-isoleucine by C. glutamicum involves 11 enzyme-catalyzed steps, at least 5 of which are regulated at the level of activity and/or expression. Recently, strains containing feedback-resistant aspartate kinase, homoserine dehydratase, and threonine dehydratase, showing significantly improved isoleucine production were constructed (5, 21) .
Significant progress in optimizing amino acid production has been achieved over the last several years. Nearly exclusively, however, the interest was focused on the metabolic level, i.e., on enzyme activities and metabolic regulation. Recently, it became obvious that in addition to these, the final step, i.e., transport of the end product across the plasma membrane, may also be relevant for production since it is an important point of control of the overall flux (17, 18) . In fact, we have characterized the presence of specific, energy-dependent, and functionally regulated excretion carrier systems for lysine, glutamate, isoleucine, and threonine in C. glutamicum. For lysine excretion in particular, the kinetic mechanism and regulation were elucidated in detail (2) (3) (4) 10) . Carrier-mediated lysine export was found to be driven by the membrane potential and the proton gradient.
The first evidence for the involvement of an isoleucine excretion carrier in C. glutamicum was provided by Ebbighausen et al. (7) . Isoleucine excretion was shown to proceed independently of the activity of the isoleucine uptake system. Isoleucine is taken up by an Na ϩ -coupled symport system with a relatively low V max of about 1.1 nmol ⅐ min Ϫ1 ⅐ mg dm Ϫ1 (8) . Isoleucine differs from lysine or glutamate in its hydrophobicity and hence in its ability to cross the membrane by diffusion. Recently, Zittrich and Krämer (27) have discriminated the three transmembrane isoleucine fluxes during isoleucine production by C. glutamicum, i.e., diffusion, carrier-mediated uptake, and carrier-mediated excretion. Isoleucine diffusion was experimentally separated and shown to proceed with a firstorder rate constant of 0.083 min Ϫ1 or 0.13 l ⅐ min Ϫ1 ⅐ mg dm Ϫ1 , corresponding to a permeability of 2 ϫ 10 Ϫ8 cm ⅐ s Ϫ1 . Carrier-mediated isoleucine excretion was zero below a threshold value of 8 mM internal isoleucine. Above this level, a Michaelis-Menten type of kinetics was observed with a K m of 21 mM (13 mM plus 8 mM threshold value) and a V max of 14.5 nmol ⅐ min Ϫ1 ⅐ mg dm Ϫ1 . To evaluate the significance of the isoleucine excretion system for the export of this amino acid under physiological and under production conditions, a detailed understanding of both its mechanism and its regulation is important. In this study, we examined the mechanism of carrier-mediated isoleucine excretion in C. glutamicum, in particular its driving forces and energy coupling. The regulation of the isoleucine excretion system at the level of expression was studied, revealing the importance of the cytoplasmic isoleucine concentration as a signal for the synthesis of the excretion carrier system.
MATERIALS AND METHODS
Growth of organisms. C. glutamicum ATCC 13032 (wild type) was grown aerobically on a rotary shaker (130 rpm) at 30ЊC. The cells were grown in a complex medium consisting of brain heart infusion (Difco) at a concentration of 37 g/liter. Before being transferred to other media, the cells were washed twice in 0.9% saline. For most experiments, minimal medium (MMI) was used: Isoleucine preloading and efflux determination. Cells were preloaded with L-isoleucine by being fed with isoleucine-containing dipeptides, e.g., L-isoleucyl-L-isoleucine (8) . By varying the quantity and composition of the added peptides, the size and duration of the steady state of the internal isoleucine pool could be adjusted. Because of its amphiphilicity, isoleucine can traverse the membrane by passive diffusion (17, 27) . Preloading of the cells was thus also possible by prolonged incubation with isoleucine ( Fig. 1) . Preloading was performed after the cells were washed as described above and resuspended in MMI at an optical density of 6 units in the presence of either L-isoleucine or L-isoleucyl-L-isoleucine dipeptide. When preloading was done by isoleucine incubation, the cells were sedimented and resuspended in ice-cold buffer, to reduce the high external isoleucine concentration, immediately before the measurement of the internal isoleucine concentration. After dilution into prewarmed MMI, the excretion was measured at 30ЊC. Figure 1 shows the course of internal isoleucine concentrations after addition of 1 mM L-isoleucyl-L-isoleucine dipeptide.
Measurement of cytoplasmic volume and membrane potential. The cytoplasmic volume was determined by silicone oil centrifugation with 3 H 2 O as the permeable marker and [
14 C]taurine as the impermeable marker (7, 8) . The mean cytoplasmic volume of C. glutamicum cells was determined to 1.8 l ⅐ mg dm Ϫ1 . The average taurine space was 3.8 l ⅐ mg dm
Ϫ1
. The distribution of the lipophilic cation [U-
14 C]tetraphenylphosphonium bromide was used to determine the membrane potential with appropriate correction for probe binding (26) . In addition, at low membrane potentials, internal and external K ϩ concentrations were determined by flame photometry to normalize the correction factors (27) to absolute membrane potentials.
Determination of external and cytosolic amino acids. Cells (100 l) were transferred to a Beckman 400-l tube containing 30 l of 20% perchloric acid and 65 l of silicone oil (specific density, 1.03 g/ml) and centrifuged for 45 s. The supernatant was used for metabolite determination by high-performance liquid chromatography (HPLC). The cells in the perchloric acid layer were extracted by sonication, and the extracts were neutralized with KOH-triethanolamine. After centrifugation in the cold, amino acid levels in the supernatants were determined. Isoleucine was detected fluorimetrically after precolumn derivatization with o-phthaldialdhyde (Pierce, Oud-Beijerland, The Netherlands) and separation on a reversed-phase column (Hypersil octyldecyl silane; 5 m in diameter, 125 by 4 mm) with an HPLC system (HP 1090 M; Hewlett-Packard) (14) .
Calculations. If possible, transmembrane amino acid flux was determined by both the decrease of the internal concentration and the increase of the external concentration. Since isoleucine is not significantly metabolized under the conditions used, in general the two values matched perfectly. Because of a higher accuracy of the efflux kinetics at the beginning, internal isoleucine concentrations were preferred for determination of the efflux in this time range. Assuming a first-order process (single exponential decay) the efflux curves were linearized by plotting the logarithm of the internal isoleucine concentration against time. The slope thus obtained represents the (first-order) rate constant of efflux (k) according to the net efflux rate v ϭ k ⅐ ([Ile] in ). This approach is justified if short periods are used for derivation and if the internal concentration is significantly above the apparent internal transport affinity (K m ). The contribution of diffusion can thus easily be subtracted from the observed efflux of isoleucine.
Generation of diffusion potentials. For generating diffusion potentials, cells were incubated for 1 h on ice in 50 mM Tris/HCl (pH 8.0)-10 mM NaCl-100 mM sodium acetate-200 mM KCl in the presence of 100 M valinomycin. To keep the internal isoleucine concentration high, 100 mM isoleucine was added. After rapid washing in ice-cold K ϩ -free buffer, the cells were immediately diluted 15-fold into the following buffers: (i) 50 mM Tris/HCl (pH 6.5)-10 mM NaCl-100 mM KCl-10 M valinomycin to generate a ⌬pH, inside alkaline; (ii) incubation buffer to dissipate all driving forces; and (iii) 50 mM Tris/HCl (pH 8.0)-10 mM NaCl-10 M valinomycin to generate both a ⌬⌿ (K ϩ diffusion potential) and a ⌬pH (4, 25) . The K ϩ diffusion potential was adjusted to values between Ϫ150 and Ϫ30 mV by dilution into buffers containing valinomycin in the presence of appropriate external K ϩ concentrations. 
RESULTS
Regulation of isoleucine excretion by the level of carrier expression. For both lysine (11) and isoleucine production, evidence was provided for the regulation of the corresponding excretion systems by internal amino acid pools. Furthermore, the lysine excretion carrier activity depends on the metabolic state of the cells in fed-batch fermentation (15) . Similar effects were observed in isoleucine production processes (unpublished results).
To test the dependence of isoleucine excretion activity on internal isoleucine in C. glutamicum, the cytoplasmic concentration was modulated by addition of isoleucine-containing dipeptides or by diffusive preloading with isoleucine. Addition of 4 mM L-isoleucyl-L-isoleucine and passive preloading with 200 mM L-isoleucine led to a steady-state internal isoleucine pool of about 110 and 160 mM, respectively, for at least 2 h, whereas in the case of 1 mM added peptide, the increase in the internal pool was only transient (Fig. 1) . Isoleucine efflux activity was measured at different times in individual samples, taken directly from the shaking flasks. Over the course of the experiment, a significant increase in the first-order rate constant of isoleucine efflux was observed (Fig. 2 ) after either diffusive preloading or loading by peptide feeding. These data represent the carrier-mediated efflux only, since the contribution of diffusion was subtracted. To verify the dependence on de novo protein synthesis, the efflux experiment was repeated in the presence of 50 g of chloramphenicol per ml. No increase in isoleucine excretion activity was observed under these conditions (Fig. 2) . For a quantitative correlation of the cytosolic isoleucine pool to the activity of the excretion system, the internal isoleucine concentration was varied by using different loading conditions (Fig. 2) . Addition of 50 mM isoleucine led to an internal concentration of 32 mM and resulted in a weak increase in isoleucine export activity (i.e., a change in the first-order rate constant of efflux [k] from 0.17 to 0.245 min Ϫ1 ). The effect of 100 mM external isoleucine (75 mM internal isoleucine) was more pronounced; i.e., isoleucine excretion reached k ϭ 0.38 min After sedimentation and resuspension in MMI and the efflux rate was determined (Fig. 3) . In this case, the dipeptide addition was only a tool to monitor the actual activity of the isoleucine excretion system and did not lead to its induction. Since the amino acids added as potential inducers were removed by the washing step, they could not interfere with isoleucine as competitors in the excretion test. Besides isoleucine, only leucine was able to induce the isoleucine excretion system to some extent, increasing from 0.26 to 0.4 min Ϫ1 . None of the other amino acids tested showed any significant effect on the efflux rate.
Dependence of isoleucine excretion on the membrane potential and proton gradient. To evaluate the significance of isoleucine excretion in physiological terms as well as under production conditions, the determination of its mechanism and energetics, as well as its regulation, is of major interest. The effect of ionophores, which influence different components of the electrochemical potential, on isoleucine efflux is shown in Table 1 . The addition of uncouplers and ionophores which decrease ⌬⌿, e.g., valinomycin in the presence of K ϩ , inhibited isoleucine efflux. As shown previously, the cytosolic ATP concentration was not significantly reduced under these conditions (19) . This effect was investigated in more detail by varying the external K ϩ concentration in the presence of 10 M valinomycin (Fig. 4) . The logarithm of the first-order rate constant of isoleucine excretion was linearly correlated to the membrane potential from about Ϫ110 to Ϫ70 mV (Fig. 4, inset) . At values more negative than Ϫ120 mV, no further increase of efflux was observed; at values more positive than Ϫ70 mV, the contribu- FIG. 2 . Regulation of the isoleucine excretion system at the level of expression. Cells were preloaded with different amounts of isoleucine; i.e., 50 mM (É), 100 mM ({), 200 mM (Ç), and 250 mM (E), or with 4 mM L-isoleucyl-Lisoleucine dipeptide (F). The dependence on de novo protein synthesis was shown by preloading with 250 mM isoleucine in the presence of 50 g of chloramphenicol per ml (ᮀ, dashed line). The measured first-order rate constant of diffusion (0.075 min
Ϫ1
) was subtracted from the overall first-order rate constants (k) of the efflux process. FIG. 3 . Effect of various amino acids on the activity of the isoleucine excretion system. Different amounts of amino acids were added to the standard isoleucine excretion assay, i.e., isoleucine, 250 mM (s); leucine, 120 mM (F); alanine, 250 mM (Ç); valine, 250 mM (É); phenylalanine, 50 mM ({); lysinyllysine dipeptide, 4 mM (ϩ). Diffusion was subtracted from the first-order rate constants (k) (see the legend to Fig. 2 ) .   FIG. 4 . Dependence of isoleucine excretion on membrane potential. The export rate was determined by the standard assay in the presence of different external K ϩ concentrations and 10 M valinomycin. The inset shows the logarithm of the efflux rate constant plotted against the membrane potential. The data are presented in two ways, (i) after subtraction of diffusion from the first-order rate constants (k) (see the legend to Fig. 2 ) (s) and (ii) after addition of the calculated contribution of the isoleucine uptake activity to the observed rate of efflux (see the text) followed by subtraction of diffusion, as described above (Ç). For the first method of correction, the standard deviation of the experimental points is given. tion of carrier-mediated excretion became small in comparison with that of diffusion; after subtraction, this led to an increasing error in this range (Fig. 4, inset) . The data shown in this figure are presented in two ways, i.e., after subtraction of isoleucine diffusion only and after addition of the contribution of uptake.
Cotransport of ions.
A secondary, membrane potential-dependent transport mechanism for isoleucine efflux necessarily involves coupling to a cotransported ion. Variation of external Na ϩ (0.06 to 100 mM) and K ϩ (1 to 100 mM) concentrations did not influence the rate of excretion (data not shown). In addition, the influence of Na ϩ and K ϩ was investigated by the use of ionophores (Table 1) . Monensin and ETH 157 (Na ϩ ionophores) and nigericin (K ϩ ionophor) did not alter the isoleucine excretion rate significantly. Besides this, the only reasonable candidates for cotransport ions are protons (or hydroxyl ions). A change in the external pH indeed affected isoleucine export. The optimum excretion was found around pH 7, but the rate changed only fourfold between pH 6 and 9 (Fig. 5) . Linear regression of the data obtained from the Hill plot between pH 7.5 and 9.0 (inset in Fig. 5 ) gave a slope of Ϫ0.93. The two branches of the pH dependence showed a more or less similar slope.
Since the influence of a proton gradient may be hidden under the conditions of the experiment in Fig. 5 because of the presence of a much stronger driving force of the membrane potential, we repeated this experiment at a significantly reduced membrane potential, at which the influence of ⌬pH on isoleucine excretion should be more pronounced. The driving forces of isoleucine efflux were varied by clamping different K ϩ diffusion potentials, thereby establishing a ⌬pH in the presence of a significantly decreased ⌬⌿ (Ϫ70 mV). A ⌬pH of 36 mV at an external pH of 7.5 was not able to drive export in the complete absence of ⌬⌿ or to enhance the transport of isoleucine when a high ⌬⌿ of Ϫ155 mV was present (data not shown). However, by decreasing ⌬⌿ to Ϫ70 mV, a ⌬pH of 0.45 unit, inside alkaline (corresponding to 27 mV), in fact increased the first-order rate constant of excretion, after subtraction of diffusion, about fivefold, i.e., from 0.02 min Ϫ1 (⌬pH 0.2) to 0.09 min Ϫ1 (⌬pH 0.65) (Fig. 6) . To exclude a possible artifact by modulation of the excretion rate as a result of the relatively minor change in internal pH in these experiments, we varied the internal pH from 7.2 to 7.7, i.e., exactly the range of internal pH as described for the experiment in Fig. 6 , in the presence of a physiological ⌬⌿ of about Ϫ155 mV. No significant change of the isoleucine excretion activity was observed under these conditions (data not shown).
Influence of external isoleucine. Besides the membrane potential and cotransported ions, the gradient of the transport solute itself may be a driving force for the efflux. Thus, the effect of a variation of the external isoleucine concentration from 0 to 100 mM on isoleucine efflux was examined. The rate of excretion decreased with an increasing extracellular isoleucine concentration. For example, 100 mM isoleucine decreased the rate to a first-order rate constant of about 0.01 min Ϫ1 (Fig.  7) . However, if the contribution of diffusion was added or subtracted, depending on the difference between the internal FIG. 5. Influence of external pH on isoleucine efflux. Efflux was measured by the standard assay but at different pH values. The inset shows a Hill plot of the same data. Linear regression of the data gave a slope of Ϫ0.93 (Hill coefficient, n). Diffusion was substracted from the first-order rate constants (see the legend to Fig. 2 ).
FIG. 6. Proton gradient as a driving force of efflux. Various diffusion potentials were induced and measured as described in Materials and Methods section. Symbols: F, ⌬pH 0.2, inside alkaline, ⌬⌿ ϭ Ϫ70 mV; s, ⌬pH 0.65, inside alkaline, ⌬⌿ ϭ Ϫ70 mV. The logarithms of the differences between the measured values at the given times and the final value of internal isoleucine remaining at the end of the experiment (threshold value) are plotted to derive the first-order rate constants.
FIG. 7.
Correlation of the isoleucine export rate to the external isoleucine concentration. The efflux rate was determined by the standard assay at different external isoleucine concentrations. Symbols: ᮀ, original data; F, diffusion substracted from carrier-mediated isoleucine transport (see the legend to Fig. 2) . The internal isoleucine concentration at the beginning of the efflux kinetics was 60 mM. VOL. 62, 1996 ISOLEUCINE EXCRETION IN C. GLUTAMICUM 3241 on July 6, 2017 by guest http://aem.asm.org/ and external isoleucine concentrations, the rate of carriermediated excretion remained more or less constant. A significant influence on isoleucine efflux of variation of the external isoleucine concentration and of the isoleucine gradient could therefore not be detected. Substrate specificity of isoleucine excretion. It was previously observed that the addition of external amino acids (e.g., leucine) may exert an inhibitory effect on isoleucine efflux (27) . To determine directly the specificity of the isoleucine excretion system by addition of competitors at the cis (cytoplasmic) side, the effect on isoleucine excretion of a variety of amino acids and amino acid analogs, when present in the cytoplasm, was tested (Table 2 ). These compounds were externally added and were taken up either by diffusion or by transport systems leading to significant internal pools. The cytoplasmic concentration was determined, and isoleucine efflux was measured. Neither aromatic amino acids nor alanine or isoleucine analogs (aminobutyric acid, allo-isoleucine) inhibited isoleucine excretion. A weak influence of valine and of the isoleucine analog norleucine was observed. Only leucine showed a stronger effect on isoleucine excretion.
DISCUSSION
Isoleucine excretion in C. glutamicum was characterized as a membrane potential-driven, proton-coupled secondary transport mechanism regulated at the level of expression by the cytoplasmic isoleucine concentration. Among the different types of amino acid excretion systems, the export of lysine, isoleucine, and threonine in C. glutamicum seems to fall into a particular class (4, 17, 23, 27) . During growth on peptides, high cytoplasmic concentrations of these amino acids may arise, since they are not catabolized in C. glutamicum. Consequently, they have to be exported to enable growth on peptides. In addition, these export systems are characterized by a functional design well suited for efflux purposes. In all three cases, carrier-mediated export is regulated at the level of activity in being active only at internal concentrations above a certain threshold, is characterized by a low (internal) affinity for the transported amino acid, and is coupled to the electrochemical proton potential in a way that drives export of the respective amino acid (4, 10, 11) .
The properties of the isoleucine export carrier resemble those of the lysine excretion carrier in several aspects. It is a secondary transport mechanism, driven mainly by ⌬⌿ in coupling isoleucine flux to the movement of protons. The inefficiency of protons at influencing the activity of isoleucine excretion under "physiological conditions", i.e. at highly negative ⌬⌿, is not surprising and is similar to the situation observed in lysine export (3) . At a high membrane potential, the transport system acts virtually at its maximum activity, irrespective of a variation of the small contribution of ⌬pH. The carrier is specific for L-isoleucine, and only L-leucine competes to some extent at the cytoplasmic side. The discrimination of D-and L-isomers was shown previously (27) . The acceptance of more than one branched-chain amino acid by transport systems of this kind has been observed in other cases too (6, 8, 12, 22) .
Beyond these basic data, we faced problems with respect to the determination of the transport stoichiometry. To measure significant activity of the excretion carrier above its threshold value, high internal isoleucine concentrations had to be established. Under these conditions, however, diffusion becomes significant. If, at the same time, the activity of the excretion carrier has to be modulated to lower values for experimental purposes, e.g., by decreasing ⌬⌿, the experimental error of the excretion rates determined after subtraction of diffusion from the overall export rate becomes significant. This is different from most other cases in which the dependence of a transport system on ⌬⌿ has been measured. Either more hydrophilic, less permeable solutes were studied, e.g., excretion of lysine or glutamate, or uptake systems in which diffusion is in general not relevant, because of the low solute concentrations applied at the cis (external) side, were analyzed. In addition, a possible contribution of the isoleucine uptake system had to be taken into account at low excretion activity. An example of this situation is given in Fig. 4 . The first correction applied, i.e., that for diffusion, is methodically well established (27) , whereas the second one, i.e., that for uptake, is somewhat difficult. It is not possible to measure the contribution of uptake exactly under these conditions, since a significant part of the uptake carrier works in the exchange mode, not contributing to net fluxes, at very high internal isoleucine concentrations. This extent is not quantitatable because of the concomitant activity of the excretion carrier. For the correction, shown in Fig. 4 , we used the activity of the isoleucine uptake carrier at different membrane potentials (8) . Only at low membrane potentials did this additional correction become significant (Fig. 4, inset) . Taken together, when the membrane potential was changed by 60 mV, the rate constant changed by a factor of about 300 (correction for diffusion only) or about 100 (additional correction for isoleucine uptake). In principle, the use of membrane vesicles is very advantageous in studies discriminating and analyzing bacterial transport systems (24) . Besides the fact that transportactive membrane vesicles of C. glutamicum are not available, the high contribution of diffusive fluxes in the case of isoleu- In the experiment on varying the ⌬pH under conditions of reduced ⌬⌿, a change in ⌬pH by 60 mV was accompanied by an approximately 30-fold change in the excretion rate. Under the plausible assumption of rate limitation by the ⌬⌿-controlled step in the transport cycle of the isoleucine excretion carrier (4), these data can be interpreted as indicating cotransport of 2 to 2.5 (Fig. 4) or about 1.5 ( Fig. 6 ) charges together with isoleucine. This result does not contradict the derived Hill coefficient of 0.93 for the interaction of protons with the carrier, since this value only means that there is no cooperative interaction between the putative sites, irrespective of the number of binding sites. On the basis of results of kinetic reasons, we argued for the coupling mechanism for lysine being a hydroxyl ion cotransport, which is, of course, indistinguishable from a proton antiport mechanism in energetic terms (4) . Because of the difficulties in flux discrimination for isoleucine, the kinetic characterization could not be elaborated to the same extent. In summary, the most likely description of the isoleucine excretion carrier in C. glutamicum is a secondary, electrogenic isoleucine/proton antiport mechanism with a stoichiometry of presumably 2 charges per isoleucine.
The expression of the lysine excretion system in C. glutamicum was shown to be regulated by the presence and kind of carbon sources (10, 11) . The experiments reported here demonstrate that the isoleucine excretion system is influenced at the level of expression by the cytoplasmic isoleucine concentration. Irrespective of the method used to modify the internal isoleucine pool, isoleucine concentrations in the cytoplasm higher than at least 20 mM led to a significant increase of the excretion carrier activity after an induction phase of about 1 h. The extent of induction was two-to threefold. We have experimental indications that, in contrast to the results of experiments with shaking flasks as reported here, a further increase of the excretion activity can be observed under the more closely defined situation in a bioreactor (experiments not shown). Besides isoleucine, only leucine was able to induce the isoleucine excretion system to a significant extent. Interestingly, the specificity of solutes in being able to induce the excretion activity closely resembled the specificity of the carrier protein toward transport substrates.
Beside the regulation of isoleucine excretion in C. glutamicum at the expression level, regulation at the level of activity was already previously observed. The excretion system was shown to be active only if the cytoplasmic level of isoleucine exceeds a threshold of about 8 mM (27) . In addition, for the Na ϩ -coupled secondary isoleucine uptake system, an unusual type of regulation was identified; i.e., it is not expressed at low internal isoleucine concentrations (1) . This complex scenario of regulation of isoleucine transport systems in C. glutamicum can be interpreted by a scheme which contains a physiological rationale (Table 3) . Under conditions of low internal isoleucine (condition A in Table 3 ), all systems are repressed and/or switched off. If the internal isoleucine concentration exceeds about 1 mM (condition B), the uptake system becomes expressed, presumably to save the small amounts of the precious amino acid lost by diffusion. This phenomenon is called cyclic retention (13) . A cytosolic isoleucine concentration higher than about 10 mM is obviously not advantageous for the cell; therefore, the excretion system becomes switched on by regulation at the level of activity (condition C). Finally, if the cytosolic concentration exceeds 50 mM or higher (condition D), the excretion system is also expressed to high levels to effectively get rid of the internally accumulated amino acid. 
